1. Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse. Issue 8 (3rd July 2019) Authors: Goldschmidt, Neta; Horowitz, Netanel A.; Heffes, Vered; Darawshy, Fares; Mashiach, Tatiana; Shaulov, Adir; Gatt, Moshe E.; Dann, Eldad J. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 8(2019) Page Start: 1890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗